Children's exposure to perfluoroalkyl acids - a modelling approach.


Journal

Environmental science. Processes & impacts
ISSN: 2050-7895
Titre abrégé: Environ Sci Process Impacts
Pays: England
ID NLM: 101601576

Informations de publication

Date de publication:
01 Nov 2019
Historique:
pubmed: 25 9 2019
medline: 24 1 2020
entrez: 25 9 2019
Statut: ppublish

Résumé

Adults are mainly exposed to per- and polyfluoroalkyl substances (PFASs) via ingestion of food, inhalation of air and ingestion of dust, whereas for children the exposure to PFASs is largely unknown. This study aimed to reconstruct the serum concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS) and perfluorohexane sulfonic acid (PFHxS) in children after infancy up to 10.5 years of age and to test if dietary intake is the major exposure pathway for children to PFOA, PFOS and PFHxS after infancy. For this work, a dataset from a Finnish child cohort study was available, which comprised serum concentrations of the studied perfluoroalkyl acids (PFAAs) and PFAS concentration measurements in dust and air samples from the children's bedrooms. The calculated PFAA intakes were used in a pharmacokinetic model to reconstruct the PFAA serum concentrations from 1 to 10.5 years of age. The calculated PFOA and PFOS intakes were close to current regulatory intake thresholds and diet was the major exposure medium for the 10.5 year-olds. The one-compartment PK model reconstructed median PFOA and PFOS serum concentrations well compared to corresponding measured median serum concentrations, while the modelled PFHxS serum concentrations showed a constant underestimation. The results imply that children's exposure to PFOA and PFOS after breastfeeding and with increasing age resembles the exposure of adults. Further, the children in the Finnish cohort experienced a rather constant exposure to PFOA and PFOS between 1 and 10.5 years of age. The PFHxS exposure sources and respective pharmacokinetic parameter estimations need further investigation.

Identifiants

pubmed: 31549993
doi: 10.1039/c9em00323a
doi:

Substances chimiques

Alkanesulfonic Acids 0
Caprylates 0
Dust 0
Environmental Pollutants 0
Fluorocarbons 0
Sulfonic Acids 0
perfluorohexanesulfonic acid 355-46-4
perfluorooctanoic acid 947VD76D3L
perfluorooctane sulfonic acid 9H2MAI21CL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1875-1886

Auteurs

Fabian G P Balk (FGP)

Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Svante Arrhenius väg 8c, 10691 Stockholm, Sweden. Ian.Cousins@aces.su.se Fabian.Balk@eawag.ch and Department of Environmental Toxicology, Swiss Federal Institute of Aquatic Science and Technology, Überlandstrasse 133, 8600 Dübendorf, Switzerland.

Kerstin Winkens Pütz (K)

Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Svante Arrhenius väg 8c, 10691 Stockholm, Sweden. Ian.Cousins@aces.su.se Fabian.Balk@eawag.ch and Department of Environmental Research and Monitoring, Swedish Museum of Natural History, P.O. Box 50007, 10405 Stockholm, Sweden.

Anton Ribbenstedt (A)

Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Svante Arrhenius väg 8c, 10691 Stockholm, Sweden. Ian.Cousins@aces.su.se Fabian.Balk@eawag.ch.

Melissa I Gomis (MI)

Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Svante Arrhenius väg 8c, 10691 Stockholm, Sweden. Ian.Cousins@aces.su.se Fabian.Balk@eawag.ch and Université Paris-Saclay, 91190 Saint-Aubin, France.

Marko Filipovic (M)

Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Svante Arrhenius väg 8c, 10691 Stockholm, Sweden. Ian.Cousins@aces.su.se Fabian.Balk@eawag.ch and NIRAS Sweden AB, Fleminggatan 14, Box 70375, 107 24 Stockholm, Sweden.

Ian T Cousins (IT)

Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Svante Arrhenius väg 8c, 10691 Stockholm, Sweden. Ian.Cousins@aces.su.se Fabian.Balk@eawag.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH